Drug intelligence / Profile preview

linghe granules

Development stage: Unknown
Lead developer: Xiamen Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Linghe granules (苓荷颗粒) is a Traditional Chinese Medicine (TCM) formulation developed by Xiamen Hospital of TCM for the treatment of metabolic disorders. The preparation is primarily composed of botanical extracts, including Poria cocos (Fuling) and Nelumbo nucifera (Lotus leaf), which are traditionally used in TCM to resolve dampness, strengthen the spleen, and promote diuresis. It is currently under clinical investigation for its efficacy in treating metabolically associated fatty liver disease (MAFLD) and obesity, where it is intended to reduce hepatic fat accumulation and improve metabolic parameters such as lipid profiles and insulin sensitivity.

Brand names: Linghe
Other names: 苓荷颗粒Linghe Keli

Beyond the preview

Go deeper on linghe granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on linghe granules.

Explore the full profile